Contineum Therapeutics, Inc.
CTNM
$9.80
-$0.59-5.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.04M | -15.99M | -14.57M | -10.27M | -9.01M |
| Total Depreciation and Amortization | 79.00K | 78.00K | 75.00K | 62.00K | 60.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.23M | 2.58M | 1.34M | 1.72M | 659.00K |
| Change in Net Operating Assets | -1.93M | -1.08M | 2.95M | 2.32M | -209.00K |
| Cash from Operations | -15.66M | -14.41M | -10.20M | -6.17M | -8.50M |
| Capital Expenditure | -44.00K | -47.00K | -166.00K | -82.00K | -119.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 20.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.93M | 14.96M | -9.22M | -30.12M | -38.78M |
| Cash from Investing | 13.88M | 14.92M | -9.39M | -30.18M | -38.90M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 267.00K | 24.00K | 642.00K | 13.00K | 108.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -176.00K | -- | -- | -- | 140.00K |
| Cash from Financing | 91.00K | 24.00K | 642.00K | 13.00K | 108.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.69M | 527.00K | -18.95M | -36.34M | 60.97M |